These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 33870575)

  • 1. Utilisation of cytological samples for multiplex immunofluorescence assay.
    Tobar LG; Villalba-Esparza M; Abengozar-Muela M; Alvarez Gigli L; Echeveste JI; de Andrea CE; Lozano MD
    Cytopathology; 2021 Sep; 32(5):611-616. PubMed ID: 33870575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the immune microenvironment of NSCLC by multispectral analysis of multiplex immunofluorescence images.
    Surace M; Rognoni L; Rodriguez-Canales J; Steele KE
    Methods Enzymol; 2020; 635():33-50. PubMed ID: 32122552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue.
    Parra ER; Ferrufino-Schmidt MC; Tamegnon A; Zhang J; Solis L; Jiang M; Ibarguen H; Haymaker C; Lee JJ; Bernatchez C; Wistuba II
    Sci Rep; 2021 Apr; 11(1):8511. PubMed ID: 33875760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplex immunofluorescence and single-cell transcriptomic profiling reveal the spatial cell interaction networks in the non-small cell lung cancer microenvironment.
    Peng H; Wu X; Liu S; He M; Xie C; Zhong R; Liu J; Tang C; Li C; Xiong S; Zheng H; He J; Lu X; Liang W
    Clin Transl Med; 2023 Jan; 13(1):e1155. PubMed ID: 36588094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex immunofluorescence staining and image analysis assay for diffuse large B cell lymphoma.
    Lee CW; Ren YJ; Marella M; Wang M; Hartke J; Couto SS
    J Immunol Methods; 2020 Mar; 478():112714. PubMed ID: 31783023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients.
    Mezheyeuski A; Bergsland CH; Backman M; Djureinovic D; Sjöblom T; Bruun J; Micke P
    J Pathol; 2018 Apr; 244(4):421-431. PubMed ID: 29282718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment.
    Viratham Pulsawatdi A; Craig SG; Bingham V; McCombe K; Humphries MP; Senevirathne S; Richman SD; Quirke P; Campo L; Domingo E; Maughan TS; James JA; Salto-Tellez M
    Mol Oncol; 2020 Oct; 14(10):2384-2402. PubMed ID: 32671911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of fine needle aspiration cytology and core biopsy histopathology with or without immunohistochemical staining in the subtyping of the non-small cell lung carcinomas: Experience from an academic centre in Turkey.
    Bayrak BY; Paksoy N; Vural Ç
    Cytopathology; 2021 May; 32(3):331-337. PubMed ID: 33145811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC).
    Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC
    Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 19, carcinoembryonic antigen, and epithelial cell adhesion molecule detect lung cancer lymph node metastasis in endobronchial ultrasound-guided transbronchial aspiration samples.
    Bugalho A; Martins C; Dias SS; Nunes G; Silva Z; Correia M; Marques Gomes MJ; Videira PA
    Clin Lung Cancer; 2013 Nov; 14(6):704-12. PubMed ID: 23886796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches.
    Parra ER; Villalobos P; Behrens C; Jiang M; Pataer A; Swisher SG; William WN; Zhang J; Lee J; Cascone T; Heymach JV; Forget MA; Haymaker C; Bernatchez C; Kalhor N; Weissferdt A; Moran C; Zhang J; Vaporciyan A; Gibbons DL; Sepesi B; Wistuba II
    J Immunother Cancer; 2018 Jun; 6(1):48. PubMed ID: 29871672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer.
    Sanchez K; Kim I; Chun B; Pucilowska J; Redmond WL; Urba WJ; Martel M; Wu Y; Campbell M; Sun Z; Grunkemeier G; Chang SC; Bernard B; Page DB
    Breast Cancer Res; 2021 Jan; 23(1):2. PubMed ID: 33413574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of Ventana SP263 PD-L1 assay in endobronchial ultrasound guided-fine-needle aspiration derived non-small-cell lung carcinoma samples.
    Chauhan A; Siegel L; Freese R; Racila E; Stewart J; Amin K
    Diagn Cytopathol; 2021 Mar; 49(3):355-362. PubMed ID: 33142053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population alterations of L-arginase- and inducible nitric oxide synthase-expressed CD11b+/CD14⁻/CD15+/CD33+ myeloid-derived suppressor cells and CD8+ T lymphocytes in patients with advanced-stage non-small cell lung cancer.
    Liu CY; Wang YM; Wang CL; Feng PH; Ko HW; Liu YH; Wu YC; Chu Y; Chung FT; Kuo CH; Lee KY; Lin SM; Lin HC; Wang CH; Yu CT; Kuo HP
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):35-45. PubMed ID: 19572148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations.
    Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S
    Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
    Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
    Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additional diagnostic value of tumor markers in cytological fluid for diagnosis of non-small-cell lung cancer.
    Hur J; Lee HJ; Nam JE; Kim YJ; Hong YJ; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Lee HS; Choi BW
    BMC Cancer; 2012 Sep; 12():392. PubMed ID: 22954172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytology-based treatment decision in primary lung cancer: is it accurate enough?
    Sakr L; Roll P; Payan MJ; Liprandi A; Dutau H; Astoul P; Robaglia-Schlupp A; Loundou A; Barlesi F
    Lung Cancer; 2012 Mar; 75(3):293-9. PubMed ID: 21975144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of Macrophage Phenotypes in Resectable Non-Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry.
    Rakaee M; Busund LR; Jamaly S; Paulsen EE; Richardsen E; Andersen S; Al-Saad S; Bremnes RM; Donnem T; Kilvaer TK
    Neoplasia; 2019 Mar; 21(3):282-293. PubMed ID: 30743162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.